Literature DB >> 9192901

Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine.

G Flatau1, E Lemichez, M Gauthier, P Chardin, S Paris, C Fiorentini, P Boquet.   

Abstract

Pathogenic Escherichia coli are responsible for a variety of diseases, including diarrhoea, haemolytic uraemic syndrome, kidney infection, septicaemia, pneumonia and meningitis. Toxins called cytotoxic necrotizing factors (CNFs) are among the virulence factors produced by uropathogenic (CNF1) or enteropathogenic (CNF2) E. coli strains that cause diseases in humans and animals, respectively. CNFs induce an increase in the content of actin stress fibres and focal contacts in cultured cells. Effects of CNFs on the actin cytoskeleton correlated with a decrease in the electrophoretic mobility of the GTP-binding protein Rho and indirect evidence indicates that CNF1 might constitutively activate Rho. Here we show that CNF1 catalyses the deamidation of a glutamine residue at position 63 of Rho, turning it into glutamic acid, which inhibits both intrinsic GTP hydrolysis and that stimulated by its GTPase-activating protein (GAP). Thus, this deamidation of glutamine 63 by CNF1 leads to the constitutive activation of Rho, and induces the reorganization of actin stress fibres. To our knowledge, CNF1 is the first example of a bacterial toxin acting by deamidation of a specific target protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192901     DOI: 10.1038/42743

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  187 in total

1.  The p21 Rho-activating toxin cytotoxic necrotizing factor 1 is endocytosed by a clathrin-independent mechanism and enters the cytosol by an acidic-dependent membrane translocation step.

Authors:  S Contamin; A Galmiche; A Doye; G Flatau; A Benmerah; P Boquet
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

2.  Induced expression of Rnd3 is associated with transformation of polarized epithelial cells by the Raf-MEK-extracellular signal-regulated kinase pathway.

Authors:  S H Hansen; M M Zegers; M Woodrow; P Rodriguez-Viciana; P Chardin; K E Mostov; M McMahon
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Localization of functional domains of the mitogenic toxin of Pasteurella multocida.

Authors:  G D Pullinger; R Sowdhamini; A J Lax
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

4.  Recombinant Yersinia YopT leads to uncoupling of RhoA-effector interaction.

Authors:  I Sorg; U M Goehring; K Aktories; G Schmidt
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Activation of rho GTPases by cytotoxic necrotizing factor 1 induces macropinocytosis and scavenging activity in epithelial cells.

Authors:  C Fiorentini; L Falzano; A Fabbri; A Stringaro; M Logozzi; S Travaglione; S Contamin; G Arancia; W Malorni; S Fais
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

6.  Escherichia coli cytotoxic necrotizing factor and Pasteurella multocida toxin induce focal adhesion kinase autophosphorylation and Src association.

Authors:  W Thomas; G D Pullinger; A J Lax; E Rozengurt
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 7.  Escherichia coli translocation at the blood-brain barrier.

Authors:  K S Kim
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

8.  Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 Gene.

Authors:  W Thomas; Z K Ascott; D Harmey; L W Slice; E Rozengurt; A J Lax
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

9.  Biological activity of a C-terminal fragment of Pasteurella multocida toxin.

Authors:  C Busch; J Orth; N Djouder; K Aktories
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

10.  Effects of cytotoxic necrotizing factor 1 and lethal toxin on actin cytoskeleton and VE-cadherin localization in human endothelial cell monolayers.

Authors:  V Vouret-Craviari; D Grall; G Flatau; J Pouysségur; P Boquet; E Van Obberghen-Schilling
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.